{"name":"Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","slug":"prometheus-biosciences-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PRA023 IV High Dose","genericName":"PRA023 IV High Dose","slug":"pra023-iv-high-dose","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"PRA023 IV High Dose","genericName":"PRA023 IV High Dose","slug":"pra023-iv-high-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxPY25oVnVPZVJhaFl3OXdmcWZsRXpwRTVDQ0pfUlNpSzFQUXZNemZqd1RDcjVOQ1FrQ0pUM2pxX2dtZi12Q3dDWjBYLUR6cXNuUDU4OXhUaHpZMDZaOExCUHk5ZTNMdzBuM1JXbTJaWlNtREhCM01hN3V6UmMxRmY2UDdSMzFqWDNFeHd2RWZORmFPWHgwTzRRLUE5X3VqRjVPQTk5MVQwXzJmSmdpT3c0NEZVS0E4X3BDQktYQ0dOQ1M1WnlDZGd1c1dSekJVdC1xbzVmME5GRXJtS014NnVBWXg0MkFFYlZic0I1UDhUbFJpR1ViRUh3SnJlOGFGYnY0LVQtRWF0aTc4WGlWMGR3b1NhcklGMVdsYU5fMG1DNk5GVHZjREdVa0swQ0FwUGpXcmFmSGxMSjB1QQ?oc=5","date":"2025-11-05","type":"pipeline","source":"BioSpace","summary":"Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody - BioSpace","headline":"Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiPEFVX3lxTFBBMmxYeUI3R2xyRmlYa0JWUW9KcTVEbnk0ZlhrRGRjdVFCS054ZGdhYlFJdW5tdktnM0hUMA?oc=5","date":"2025-10-14","type":"pipeline","source":"Ad Age","summary":"Merck—ad spending, facts and profile - Ad Age","headline":"Merck—ad spending, facts and profile","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-09","type":"deal","source":"Mint","summary":"Merck to buy UK’s Verona Pharma for $10 billion in bid to diversify beyond cancer treatment - Mint","headline":"Merck to buy UK’s Verona Pharma for $10 billion in bid to diversify beyond cancer treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOSVdBU2dOSUNyX3VZMmhmWlVNcFp0UjZNWlVVblB1MnlGLWdfR29PWVoyZkROTndFZW4zcV9uQThzMVlZVjg3Q3NOZ1cyUFZfZVR1cGtnczhmcEQ2M3NUUFF1WHRaLU1UZnNNbVFIbzh6TFhacFVBZ3I1VGRSenl3bQ?oc=5","date":"2025-03-31","type":"pipeline","source":"Fierce Biotech","summary":"The top 10 pharma R&D budgets for 2024 - Fierce Biotech","headline":"The top 10 pharma R&D budgets for 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFB0UGs3SEFpZVVVZUstS1pKNm5RSl9JRnItVHFwNHhVOTZoNnhjQWpTN2VzWURNbWh5Zm5ZV0FRejNUZUMwaHFvdVJzaVkxV3RmTk1HNi1uQ3lRWGZBVjQzY0d3?oc=5","date":"2024-09-11","type":"pipeline","source":"scoop.market.us","summary":"Top 10 Smart Pill Providers | Top Medical Technology - scoop.market.us","headline":"Top 10 Smart Pill Providers | Top Medical Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQajVidDhlSzhIRVVBUUM4T0xQdzN1Vk11SDFxTlIzdkRwWS02bnJOZXlxNnhWNXNGRGdFMmx3VW9HZjNKb1hDWXRqMzNTaENXVXczOVZBTGtWOWRpekpOUFc4d0JEa2lZTTA5YVJfeXN5N1BhU0szQnZXR0lYR3Z3Y3JIQkswY3FXQ0I3ZXNtMEg?oc=5","date":"2023-06-24","type":"pipeline","source":"San Diego Business Journal","summary":"Merck Closes Prometheus Acquisition - San Diego Business Journal","headline":"Merck Closes Prometheus Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPRzVkRGFicXN5RlN2Vi1kcERIU1ZkMFIxb0M4TmNpTnJibG1CRWFIOTlFVE12ODExNzhPZ1EyQm9vSGRfOFZzMmFjRHdzWmFXYTZIb0IzRTBnc1Z0MlNNUnRjQ25TVml4WnFSVGdla2pRSzN4TlhYa2M0WDlXNkpTbmVlRnp6RDhUUTM2YzNlMEU1eTRHQTNJaGtyNjNsX0UxNWxPNFYzOTdxQmdseVVIUDhqbUQ?oc=5","date":"2023-05-01","type":"pipeline","source":"Bloomberg.com","summary":"AbbVie, Bristol Myers Vied for Prometheus Before Merck Bought It - Bloomberg.com","headline":"AbbVie, Bristol Myers Vied for Prometheus Before Merck Bought It","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9XTW12NUo2dEx2dHh5N01sNC1FZzBQWndQYUFkOVFoSEhKWm1fQ1Zael9CR3FCemRLcjIwdDZ4R3BRV1lpZ08zNklTTEF6N1dra1Raemg5bDN4M2hYcU14WEpPckliLUhub0hvd1U1VW1EdHV5dHhtQzFR0gF_QVVfeXFMT1JKSkxrVS1hZVdoTjFBQ0dUZ0hxZEEyd1VoNEU3azgycjJhazdjUkZoNE5Ub2Jtcml6RXh3M1ptWW5jU1pNbl9vaEFEUVpxeHBsNWNxRjRtc09vdXktWF9aNWVVQ21GSE5JZTRpUnd6N05GZjFTMC13NVZJNkRtdw?oc=5","date":"2023-04-27","type":"pipeline","source":"CNBC","summary":"Merck results beat expectations despite a big drop in sales of Covid antiviral treatment - CNBC","headline":"Merck results beat expectations despite a big drop in sales of Covid antiviral treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNV1N3OERROHNMR1hJejNZZk8zaGdMSmtJaHB6Qzdna1lfZVdkSXVXemJRSGZ3SjFlMmxGZW85dWZHQWdFNTRZaGl0dzhZWmlYTG5BbTZmRGZxemg3VUhqUjMydFNZTndyYVZ6UWFFbWVNVGJNTHhUYlNpUE9WZWRtMUJ1VFdSX1V2bDJkWnI3Vm9rTi1ib2NpYWNmc3BldVRXRm5XQWRXRFdfbTlXTUlTWFo3Z3R3VnVzU2ptellkaUl1Zw?oc=5","date":"2023-04-18","type":"deal","source":"C&EN","summary":"Merck pays premium prices to acquire Prometheus Biosciences - C&EN","headline":"Merck pays premium prices to acquire Prometheus Biosciences - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOUVpuWUlxY0FKWWxGazBna2U4M2tPRVBOdnZFODZTUnpfRm9lcHIySGpPMUw3aXBXS2ZvdnVvYVRodXlFV1dvNWVSWTdPWXF5ZDdzQUJGVXI2dnVXX3hVVl8tYzFTbW9QaFFURnFRSnZ0aWVZdFNiUXNNQk1XTFowd3hzM0s3anF6aUNVZFlIdmJRUi1KdHdQUmFlUnU5NmdHRjZKSnhTdFFCcjA?oc=5","date":"2023-04-17","type":"patent","source":"Bloomberg.com","summary":"Merck to Cushion Patent Loss With Prometheus Acquisition - Bloomberg.com","headline":"Merck to Cushion Patent Loss With Prometheus Acquisition","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}